Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
0.64
+ 0.02 (+3.29%)
Day High: 0.66
Day Low:  0.61
Volume:    234,810
4:00 PM ET on Nov 22, 2017

Delayed at least 20 minutes.